GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (NYSE:IQV) » Definitions » Cyclically Adjusted Price-to-FCF

IQVIA Holdings (IQVIA Holdings) Cyclically Adjusted Price-to-FCF : 36.42 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is IQVIA Holdings Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), IQVIA Holdings's current share price is $234.88. IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $6.45. IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is 36.42.

The historical rank and industry rank for IQVIA Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

IQV' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 28.25   Med: 38.46   Max: 60.37
Current: 36.26

During the past years, IQVIA Holdings's highest Cyclically Adjusted Price-to-FCF was 60.37. The lowest was 28.25. And the median was 38.46.

IQV's Cyclically Adjusted Price-to-FCF is ranked worse than
53.97% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 33.84 vs IQV: 36.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IQVIA Holdings's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $3.079. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $6.45 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IQVIA Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cyclically Adjusted Price-to-FCF Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 58.00 35.63 35.85

IQVIA Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.63 32.95 36.04 30.90 35.85

Competitive Comparison of IQVIA Holdings's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted Price-to-FCF falls into.



IQVIA Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IQVIA Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=234.88/6.45
=36.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, IQVIA Holdings's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.079/129.4194*129.4194
=3.079

Current CPI (Dec. 2023) = 129.4194.

IQVIA Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.347 99.695 -0.450
201406 0.371 100.560 0.477
201409 0.882 100.428 1.137
201412 1.803 99.070 2.355
201503 -0.634 99.621 -0.824
201506 0.279 100.684 0.359
201509 2.060 100.392 2.656
201512 1.506 99.792 1.953
201603 0.708 100.470 0.912
201606 0.082 101.688 0.104
201609 1.972 101.861 2.506
201612 1.534 101.863 1.949
201703 -0.094 102.862 -0.118
201706 0.652 103.349 0.816
201709 1.584 104.136 1.969
201712 0.612 104.011 0.762
201803 0.443 105.290 0.545
201806 0.958 106.317 1.166
201809 1.069 106.507 1.299
201812 1.368 105.998 1.670
201903 -0.139 107.251 -0.168
201906 1.176 108.070 1.408
201909 0.910 108.329 1.087
201912 2.265 108.420 2.704
202003 0.112 108.902 0.133
202006 1.729 108.767 2.057
202009 2.140 109.815 2.522
202012 2.939 109.897 3.461
202103 3.684 111.754 4.266
202106 2.022 114.631 2.283
202109 3.492 115.734 3.905
202112 2.605 117.630 2.866
202203 1.711 121.301 1.826
202206 0.879 125.017 0.910
202209 3.685 125.227 3.808
202212 2.064 125.222 2.133
202303 1.341 127.348 1.363
202306 1.296 128.729 1.303
202309 2.356 129.860 2.348
202312 3.079 129.419 3.079

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (NYSE:IQV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IQVIA Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (IQVIA Holdings) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Executives
Kevin C Knightly officer: Pres Info & Tech Solutions 1499 POST ROAD, FAIRFIELD CT 06824
Panagos Constantinos officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Eric Sherbet officer: See Remarks 100 IMS DRIVE, PARSIPPANY NJ 07054-4235
Keriann Cherofsky officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Sheila A Stamps director C/O CIT GROUP, 1 CIT DRIVE, ATTN: GENERAL COUNSEL, LIVINGSTON NJ 07039
Morris Leslie Wims director 4280 EMPEROR BLVD, DURHAM NC 27703
John Connaughton director, 10 percent owner BAIN CAPITAL PARTNERS LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Ronald E Bruehlman officer: See Remarks C/O IQVIA HOLDINGS, INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Ari Bousbib director, officer: Chairman, CEO & Pres UNITED TECHNOLOGIES CORP, ONE FINANCIAL PLAZA, HARTFORD CT 06101
W Richard Staub officer: See Remarks
Tpg Group Holdings (sbs) Advisors, Inc. 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Michael J Evanisko director BRAUN CONSULTING, 20 W KINZIE STREET SUITE 1600, CHICAGO IL 60610
Michael R Mcdonnell officer: Chief Financial Officer C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
John M. Leonard director C/O INTELLIA THERAPEUTICS INC, 40 ERIE STREET, SUITE 130, CAMBRIDGE MA 02139

IQVIA Holdings (IQVIA Holdings) Headlines